Brain+ establishes UK subsidiary
Copenhagen, Denmark, 17 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · With the incorporation of Brian+ UK Limited, Brain+ has established legal presence in the UK · The UK is currently the most mature and attractive market for the company’s software-based dementia therapies · The establishment of a legal UK entity opens access to · commercial opportunities in the UK healthcare system, and · funding resources, including UK healthcare grants · The move is an important step in the execution of Brain+’ UK focused commercial strategyBrain+ A/S (“Brain+” or “